The IBEC among the six Catalan centers that have received the TECNIO seal this year. This accreditation allows SMEs and companies to identify centers that offer differential technology and increase innovation rates.
The Government of Catalonia has accredited the Institute of Bioengineering of Catalonia (IBEC) with the TECNIO seal. ACCIO – the Agency for the competitiveness of the company, under the Department of Enterprise and Knowledge -, has accredited this year six new centers with this seal.
El proyecto ISCHEMSURG, que persigue combatir la isquemia asociada a la cirugía regenerativa, ha recibido financiación de la Agencia de Gestión de Ayudas Universitarias y de Investigación (AGAUR) destinados a la obtención de prototipos y a la valorización i transferencia de resultados de investigación.
ISCHEMSURG desarrollará un sensor electroquímico miniaturizado para el control no invasivo en tiempo real de la isquemia tisular en el postoperatorio. Esta tecnología aportará una solución efectiva y asequible a esta necesidad que aún no tiene solución.
Four projects coordinated by 2 group leaders and 2 researchers from IBEC have been successful in gaining funding through the Barcelona Institute of Science and Technology’s IGNITE call.
The BIST Ignite Programme is a mechanism to foster multidisciplinary research among the BIST members. Its goal is to promote new collaboration between its partners, facilitating the exchange of knowledge among different scientific fields and exploring new approaches. The projects that can be eligible for the grants must pursue the exploration of new questions and technological challenges through novel multidisciplinary approaches. The selected projects are granted with 20.000€ each and researchers will have 8 months to develop their projects.
The programme IBEC Faster Future, an initiative that aims to help accelerate research projects that are close to tackling major challenges in health, will enable the development of a new antibody that will be the base of a therapeutic product for the treatment of Parkinson’s disease.
The Faster Future program campaign “Let’s tackle Parkinson”, which is launched today and will remain open to donations until the 30th of April, has the aim to raise 50,000 € needed to accelerate this research, seeking to obtain favourable results within a year and a half.
The Spanish Platform for Nanomedicine (NanoMedSpain) coordinated by Josep Samitier, director of IBEC, has participated once again in the Annual Conference of Technological Platforms of Biomedical Research that took place in Madrid during the days 5 an 6 of March.
This yearly conference, organised by the four national platforms Farmaindustria, Asebio, NanomedSpain and FENIN -Innovative medicines, nanomedicine, sanitary technology and biotechnological markets- where the main issue was how to boost biomedical research hubs in Spain. During the morning of the 5th of March, the directors of each platform presented a summary of their activity during 2018, after which their invited speakers gave talks. This year, NanomedSpain has invited Per Matsson, president of EIT Health Scandinavia and CTO at Thermo Fisher Scientific Immunodiagnostics whose speech was entitled “Innovation in health: from biomarker discovery to implementation”.
Pere Roca-Cusachs, group leader at IBEC and assistant professor at the University of Barcelona, has won the 2019 Young Investigator Prize for his contributions to the field of mechanobiology. The award is given by the European Biophysical Societies Association (EBSA).
EBSA association grants this prize every two years. The last winner of the prize was Philipp Kukura from the University of Oxford in the UK in 2017. The prize recognises an investigator who has defended his thesis 12 years ago or less across Europe and awards him with 2000€ and a medal as well as be expected to contribute an article to the European Biophysics Journal.
The MECHANO·CONTROL consortium, led by several research institutions across Europe, is launching a Summer School that will be taking place between 17-20 of September 2019 at the Eco Resort in La Cerdanya. The aim of the summer school is to provide training on mechanobiology, and specifically its application to breast cancer.
This school will include lectures as well as practical workshops in different techniques and disciplines, ranging from modelling to biomechanics to cancer biology. There will be scientific sessions in the morning, mixing 6 keynote speakers with 18 short talks selected from abstract submissions by junior scientists attending the school. In the afternoon, there will be 2-3-hour practical workshops, given by scientists from the MECHANO·CONTROL consortium. The course will also include leisure activities.
The Institute for Bioengineering of Catalonia (IBEC) has signed an agreement for an initial investment round of one and a half million euros with Scranton Entreprises B.V. -an investment association headquartered in the Netherlands-, with the aim of developing technology that predicts the probability of implantation of embryos obtained through in vitro fertilization.
This agreement is the first to be established within the framework of the institute’s new initiative, the Open Innovation Lab, that offers companies and investors a platform to bring the cutting-edge research to patients and to the market faster.
The Instiute of Bioengineering of Catalonia (IBEC) has brought together in the same act the American physicist Jerome Friedman, Nobel Prize in Physics in 1990, and the Israeli crystallographer Ada Yonath, Nobel Prize in Chemistry in 2009.
Both researchers, who are in Barcelona for the biennial “Ciutat i Ciència” organized by Institut de Cultura de l’Ajuntament de Barcelona, have coincided in this event on the International Day of Women and Girls in Science.
Last Friday the IBEC-managed Spanish Nanotechnology Platform, NanoMed Spain, co-hosted the sixth edition of Health TECH World Cancer Day, a global initiative organized as part of World Cancer Day.
It’s the fourth year running that the platform has hosted the conference, which took place at the headquarters of the Asociación Española Contra el Cáncer (AECC) in Barcelona and was opened by Laureano Molins, president de AECC Cataluña and IBEC/NanoMed Spain’s Josep Samitier, who also gave a presentation about the platform.